DPDong-Hyuk Park

Dong-Hyuk Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dong-Hyuk Park has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Shin-Hyuk Kang

    Department of Neurosurgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea

    14 shared publications
  • Kyung-Jae Park

    Department of Neurosurgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea

    9 shared publications
  • Jang Hun Kim

    Department of Neurosurgery Korea University Anam Hospital Korea University College of Medicine Seoul Korea

    6 shared publications
  • Jong-Hoon Kim

    Laboratory of Stem Cells and Tissue Regeneration, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, South Korea

    6 shared publications
  • Yong-Gu Chung

    Department of Neurosurgery, Korea University Medical Center, Korea University College of Medicine, Seoul, South Korea

    6 shared publications
  • Dongho Geum

    Department of Medical Science, College of Medicine, Korea University, Seoul, Korea

    5 shared publications

Latest Publications

  • Open Access

    Neuroprotective Effects of Human Adipose Tissue-Derived Mesenchymal Stromal Cells Against Radiation-Induced Neural Damage : A Comparative In Vitro Study

    by Jang Hun Kim, Chul Young Kim, Jong-Hoon Kim, Dongho Geum, Dong-Hyuk Park

    Objective : Radiotherapy is a key treatment for brain tumors and arteriovenous malformations; however, it is associated with adverse effects such as brain edema, demyelination, and delayed necrosis. These adverse effects are driven by inflammation and apoptosis, initiated by cytokines such as tumor necrosis factor-α, transforming growth factor, and interleukin-1β. Adipose tissuederived mesenchymal stromal cells (ADMSCs) offer protection against radiation-induced damage owing to their pluripotency and antiinflammatory properties. In this study, we investigated the neuroprotective effects of ADMSCs on irradiated brain cells.Methods : Rat cortical neurons, human glioblastoma cells (U87 cell line), and ADMSCs were exposed to radiation doses ranging from 3 Gy to 40 Gy. Co-cultures of irradiated neurons with ADMSCs or their secretomes were assessed for apoptotic and inflammatory markers. Cell viability was measured using lactate dehydrogenase (LDH) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Apoptosis was determined by using Hoechst staining and western blot analysis of proteins such as Bax, caspase-3, and Bcl-2.Results : Higher radiation doses (30–40 Gy) significantly increased apoptosis and decreased the viability of cortical neurons and U87 cells. Co-culture with ADMSCs reduced the levels of apoptosis markers, particularly Bax and cleaved caspase-3, and promoted cell survival. Direct co-culture provided more pronounced protection than did ADMSC secretome treatment, suggesting that cell-to-cell interactions are crucial for neuroprotection.Conclusion : ADMSCs have a significant potential for mitigating radiation-induced brain damage by reducing apoptosis and inflammation. Direct ADMSC co-culture outperformed secretome treatment, thereby emphasizing the importance of physical cell interactions. ADMSC therapy may be a promising approach to protect against radiotherapy-induced neural damage. Further studies are required to optimize the delivery and timing of stem cell therapy.


  • Open Access

    Bridging Inflammation and Repair: The Promise of MFG-E8 in Ischemic Stroke Therapy

    by Ye-Jin Han, Hye-Jin Lee, Dong-Ho Geum, Jong-Hoon Kim, Dong-Hyuk Park

    Ischemic stroke is a neurological disorder resulting from localized brain injury due to focal cerebral ischemia, typically caused by the blockage of one or, in some cases, a few cerebral arteries. This arterial obstruction leads to hypoxia and energy failure, culminating in primary brain damage. Although reperfusion is critical to salvage viable tissue, it often intensifies injury through oxidative stress, inflammation, and cell death—a phenomenon called ischemia–reperfusion (I/R) injury. Milk fat globule-EGF factor 8 (MFG-E8), a multifunctional glycoprotein secreted by stem and immune cells, is a key regulator of inflammation and tissue repair. By modulating microglial activation, attenuating proinflammatory cytokine releases, and preserving neuronal integrity, MFG-E8 mitigates ischemia–reperfusion injury and emerges as a novel therapeutic target for ischemic stroke.


  • Open Access

    Efficacy of Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cell Replacement Therapy in a Vascular Dementia Animal Model

    by Jang Hun Kim, Ho-Young Kang, Jihun Lee, Jong-Hoon Kim, Dongho Geum, Dong-Hyuk Park

    Background: Cell replacement therapy is the only treatment that restores or repairs the function of impaired tissues in neurodegenerative diseases, including vascular dementia (VaD); however, current VaD treatments focus on slowing or mitigating the underlying small vessel disease progression. We aimed to verify the improvement in neurocognition after administering human-induced pluripotent stem cell (hiPSC)-derived neural progenitor cells (NPCs) from in a VaD animal model. Methods: After anesthesia, 10–12-week-old male C5BL/6 mice underwent sham or bilateral carotid artery stenosis (BCAS) surgeries. For BCAS, 0.18-mm micro-coils were wound around the bilateral common carotid arteries to induce chronic vascular insufficiency in the global brain. One day after surgery, the mice were administered phosphate buffer solution or NPC from hiPSCs via the tail vein for 15 d, and divided into sham (n = 6), VEH (n = 6), and NPC (n = 7) groups. Three months after the surgery, neurobehavioral tests including the Y-maze test (YMT), passive avoidance test (PAT), and novel object recognition test (NORT) were performed. Finally, mice brains were sectioned for evaluating microglia (Iba-1), astrocyte (GFAP) activation, and myelin (MBP) degeneration through immunohistochemistry (IHC). Results: PAT latency (p = 0.01) and discrimination index in the NORT (p = 0.043) increased considerably in the NPC group than in the VEH group. However, alterations in YMT were not considerably higher in the NPC group than in the VEH group (p = 0.65). IHC tests revealed that the GFAP- and IBA-1-positive cell number was remarkably lower in the NPC group than in the VEH group (p < 0.05). Moreover, MBP density was higher in the NPC group. Conclusion: hiPSC-derived NPCs have therapeutic potential in cerebral hypoperfusion VaD mice; it improves the working memory of VaD animals by diminishing inflammatory reactions and protecting them from demyelination.


  • Open Access

    A Novel Mouse Model of Mixed Dementia Using Chronic Cerebral Hypoperfusion Induced by Bilateral Carotid Artery Stenosis

    by Jang Hun Kim, Ho-Young Kang, Sung Young Park, Yoo Mi Yang, Sang-Kyung Jo, Dongho Geum, Jong-Hoon Kim, Dong-Hyuk Park

    Kim JH, et al. J Korean Med Sci. 2025 Aug;40(35):e236. https://doi.org/10.3346/jkms.2025.40.e236


  • Open Access

    Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles

    by Jihun Lee, Dongho Geum, Dong-Hyuk Park, Jong-Hoon Kim

    Ischemic stroke (IS) remains a leading cause of mortality and long-term disability worldwide, with limited therapeutic options available. Despite the success of early interventions, such as tissue-type plasminogen activator administration and mechanical thrombectomy, many patients continue to experience persistent neurological deficits. The pathophysiology of IS is multifaceted, encompassing excitotoxicity, oxidative and nitrosative stress, inflammation, and blood–brain barrier disruption, all of which contribute to neural cell death, further complicating the treatment of IS. Recently, extracellular vesicles (EVs) secreted naturally by various cell types have emerged as promising therapeutic agents because of their ability to facilitate selective cell-to-cell communication, neuroprotection, and tissue regeneration. Furthermore, engineered EVs, designed to enhance targeted delivery and therapeutic cargo, hold the potential to improve their therapeutic benefits by mitigating neuronal damage and promoting neurogenesis and angiogenesis. This review summarizes the characteristics of EVs, the molecular mechanisms underlying IS pathophysiology, and the emerging role of EVs in IS treatment at the molecular level. This review also explores the recent advancements in EV engineering, including the incorporation of specific proteins, RNAs, or pharmacological agents into EVs to enhance their therapeutic efficacy.


  • Open Access

    Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles

    by Jihun Lee, Dongho Geum, Dong-Hyuk Park, Jong-Hoon Kim

    Ischemic stroke (IS) remains a leading cause of mortality and long-term disability worldwide, with limited therapeutic options available. Despite the success of early interventions such as tissue-type plasminogen activator administration and mechanical thrombectomy, many patients continue to experience persistent neurological deficits. The pathophysiology of IS is multifaceted, encompassing excitotoxicity, oxidative and nitrosative stress, inflammation, and blood-brain barrier disruption, all of which contribute to neural cell death, further complicating the treatment of IS. Recently, extracellular vesicles (EVs) secreted naturally by various cell types have emerged as promising therapeutic agents because of their ability to facilitate selective cell-to-cell communication, neuroprotection, and tissue regeneration. Furthermore, engineered EVs, designed to enhance targeted delivery and therapeutic cargo, hold potential to improve their therapeutic benefits by mitigating neuronal damage and promoting neurogenesis and angiogenesis. This review summarizes the characteristics of EVs, the molecular mechanisms underlying IS pathophysiology, and the emerging role of EVs in IS treatment at the molecular level. This review also explores the recent advancements in EV engineering, including the incorporation of specific proteins, RNAs, or pharmacological agents into EVs to enhance their therapeutic efficacy.


  • Open Access

    Primary Intracranial Ewing Sarcoma With an Unusual Presentation: A Case Report

    by Hyo-Jeong Kim, Jang Hun Kim, Kyung-Jae Park, Dong-Hyuk Park, Shin-Hyuk Kang

    Kim HJ, et al. Brain Tumor Res Treat. 2024 Apr;12(2):115-120. https://doi.org/10.14791/btrt.2024.0003


  • Open Access

    Novel mouse model of mixed dementia using chronic cerebral hypoperfusion induced by bilateral carotid artery stenosis

    by Jang Hun Kim, Ho-Young Kang, Sung Young Park, Dong-Hyuk Park

    Background Alzheimer’s disease (AD) and vascular dementia (VaD) have distinguishable pathognomonic findings, but they are common among older adults with similar clinical manifestations. Clinically, a mixed form of dementia (MD), VaD combined with AD, is frequent in older adults accounting for approximately 50% of all patients with dementia. Owing to the clinical importance and emerging changes in MD, a representative animal model is necessary for future dementia research. Aims To develop a novel MD mouse model using bilateral carotid artery stenosis (BCAS) in 5× familial AD (FAD) transgenic mice and establish their behavioral and histological characteristics Methods Thirteen C57BL/6 and sixteen 5× FAD transgenic mice were prepared. Six C57BL/6 and seven 5× FAD transgenic mice underwent BCAS surgery, and all mice were raised for 3 months. The mice were divided into four groups: wild-type (n = 7), VaD (n = 6), AD (n = 9), and MD (n = 7). Neurobehavioral tests, including the Y-maze test (YMT), passive avoidance test (PAT), and immunohistochemical confirmation, including mouse monoclonal amyloid-β antibody (MOAB-2) in the cortex/hippocampus and myelin basic protein (MBP) in the corpus callosum, were performed. Results Newly developed MD mice demonstrated poor results in YMT, similar to AD and VaD mice, and worse results for PAT compared to the other groups. Immunohistochemical analyses demonstrated that MD mice exhibited amyloid-β protein accumulation in the cortex/hippocampus (MOAB-2) and axonal degeneration in the corpus callosum (MBP). Conclusion A novel MD animal model was developed with pathognomonic findings of both AD and VaD. The neurobehavioral spectra of MD mice displayed characteristic deficits in intermediate-term memory and learning ability (PAT).

  • Open Access

    The significance of decompressive craniectomy for older patients with traumatic brain injury: a propensity score matching analysis from large multi-center data

    by Jang Hun Kim, Kyung-Jae Park, Shin-Hyuk Kang, Dong-Hyuk Park, Jong Hyun Kim

    The efficacy of decompressive craniectomy (DC) for traumatic brain injury (TBI) have been investigated in two recent randomized clinical trials (RCTs) and DC is recommended as an optional treatment for improving overall survival compared to medical treatment. However, the two RCTs enrolled extremely young adults, and the efficacy of DC in older adults remains questionable. Therefore, to identify the efficacy of DC in older adults, we compared patients who received medical care with those who underwent DC after propensity score matching (PSM). From the Korea Multi-center Traumatic Brain Injury Database, 443 patients identified as having intracranial hypertension and a necessity of DC were retrospectively enrolled. The patients were classified into the DC (n = 375) and non-DC (n = 68) groups according to operation records. The PSM was conducted to match the patients in the DC group with those receiving medical care (non-DC). After PSM, the newly matched group (DC, n = 126) was compared with patients without DC (non-DC, n = 63). The mean difference in the logit of the propensity scores (LPS) was 0.00391 and the mean age of enrolled patients were 65 years. The results of the comparative analyses after PSM showed that the 6-month mortality rate of the non-DC group was higher than that of the DC group (61.9% vs. 51.6%, p = 0.179). In terms of favorable outcomes (modified Rankin Scale [mRS] score < 4), the DC group showed a lower rate of favorable mRS scores (11.9% vs. 17.5%, p = 0.296) than the non-DC group.


  • Open Access

    Analysis of Prognostic Factors in Patients with Hemorrhagic Moyamoya Disease

    by Dong-Wook Lee, Jang-Hun Kim, Dong-Jun Lim, Dong-Hyuk Park

    Background Hemorrhagic Moyamoya disease (MMD) is a common subtype of MMD in adult patients, especially in East Asian countries. To our knowledge, current studies regarding factors affecting the prognosis in patients with hemorrhagic MMD is lacking. This study aimed to determine the potential prognostic factors for hemorrhagic MMD. Methods This retrospective study reviewed patients with hemorrhagic MMD diagnosed at our hospital between June 2011 and June 2021. Patient outcome was measured at discharge using the extended Glasgow outcome scale (GOSE). Prognostic factors were assessed by multivariate logistic regression analysis. Results Patients discharged with worst outcomes (GOSE 1 and 2) had significantly lower initial Glasgow coma scale (GCS) scores (5.9 ± 3.1 vs. 10.3 ± 3.7; p = 0.002) and were associated with more severe intraventricular hemorrhage (IVH) (p = 0.007), and IVH-related hydrocephalus requiring extraventricular drain (EVD) insertion was more common (n = 12 vs. n = 7; p = 0.001). The multivariate analysis showed that IVH-related hydrocephalus requiring EVD placement (OR 8.256, 95% CI 0.996-68.450; p = 0.016) and low initial GCS scores (OR 0.644; 95% CI 0.465-0.892; p = 0.008) were independent risk factors for unfavorable outcomes (GOSE 1-4) in patients with hemorrhagic MMD. Conclusion This study analyzed several potential prognostic factors for patients with hemorrhagic MMD. Low initial GCS scores and IVH-related hydrocephalus requiring EVD insertion were related to unfavorable outcomes.